Synapse - Kinga Hosszu

Results (46)

Ipilimumab after CD34-selected allogeneic stem cell transplantation (Allo HCT) for patients with relapsed/refractory multiple myeloma (RRMM)

Meeting Abstract

Ghosh, A.; Nagel, K.; Hosszu, K.; Datta, A.; Thompson, C.; Levia, K.; Kamrowski, A.; McAvoy, D.; Chung, D.; Landau, H.; more...
Clinical Lymphoma, Myeloma and Leukemia (2023)

Fulltext@MSK | Save

Bispecific T-cell engager response is driven by pre-treatment CD8+ effector memory cells and inhibited by TIGIT+ Tregs in relapsed/refractory multiple myeloma

Meeting Abstract

Firestone, R.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I.; Wang, A.; Zhu, M.; Patel, D.; Tan, C. R.; Hultcrantz, M.; more...
Clinical Lymphoma, Myeloma and Leukemia (2023)

Fulltext@MSK | Save

A comprehensive and collaborative workflow to establish customized endpoints and biomarkers for immunotherapy trials

Meeting Abstract

Vidal, E. H.; Mcavoy, D.; Vallone, A.; Thomsen, M.; Maslak, P.; Harris, A.; Oved, J.; Hosszu, K.; Boelens, J. J.
Cytotherapy (2023)

Fulltext@MSK | Save

Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations

Research Letter

Kunvarjee, B.; Bidgoli, A.; Madan, R. P.; Vidal, E.; McAvoy, D.; Hosszu, K. K.; Scaradavou, A.; Spitzer, B. G.; Curran, K. J.; Cancio, M.; more...
Journal of Allergy and Clinical Immunology (2023)

Fulltext@MSK | Save

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: A prospective, multicentre, observational study

Journal Article

Hill, J. A.; Martens, M. J.; Young, J. A. H.; Bhavsar, K.; Kou, J.; Chen, M.; Lee, L. W.; Baluch, A.; Dhodapkar, M. V.; Nakamura, R.; more...
eClinicalMedicine (2023)

Fulltext@MSK | Save

An ongoing pilot study of targeted radioimmunotherapy (131-I apamistamab) conditioning prior to CD19-targeted CAR T-cell therapy for relapsed or refractory B-cell acute lymphoblastic leukemia or diffuse large B-cell lymphoma

Meeting Abstract

Geyer, M. B.; Cadzin, B.; Hosszu, K.; Senechal, B.; Spross, J. A.; Mark, A.; Desai, A.; Cathcart, E. R.; Palomba, M. L.; Pandit-Taskar, N.
Blood (2022)

Fulltext@MSK | Save

A pilot plant based dietary intervention in MGUS and SMM patients with elevated BMI is feasible and associated with improvements in metabolic and microbiome biomarkers of progression

Meeting Abstract

Shah, U. A.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Tran, L.; Adintori, P. A.; Burge, M.; Funkhouser, S.; Hosszu, K.; more...
Blood (2022)

Fulltext@MSK | Save

Sustained minimal residual disease negativity in multiple myeloma is associated with stool butyrate and healthier plant-based diets

Journal Article

Shah, U. A.; Maclachlan, K. H.; Derkach, A.; Salcedo, M.; Barnett, K.; Caple, J.; Blaslov, J.; Tran, L.; Ciardiello, A.; Burge, M.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save

GPRC5D-targeted CAR T cells for myeloma

Journal Article

Mailankody, S.; Devlin, S. M.; Landa, J.; Nath, K.; Diamonte, C.; Carstens, E. J.; Russo, D.; Auclair, R.; Fitzgerald, L.; Cadzin, B.; more...
New England Journal of Medicine (2022)

Fulltext@MSK | Save

Discovery proteomics for analytes to predict cytokine release syndrome on day of infusion of chimeric antigen receptor (CAR) T cells

Meeting Abstract

Lakkaraja, M.; Hosszu, K.; Mcavoy, D.; Mauguen, A.; Purdon, T. J.; Auchincloss, T.; Klein, E.; Khakoo, Y.; Santomasso, B.; Senechal, B.; more...
Cytotherapy (2022)

Fulltext@MSK | Save